Exelixis Inc
XNAS:EXEL
| Market Cap (Intraday) | 14.43B |
| Current PE | 16.77 |
| Forward PE | 16.63 |
| 2yr Forward PE | 14.06 |
| 10-Day MA | $57.38 |
| 50-Day MA | $55.39 |
| 200-Day MA | $48.30 |
Exelixis Inc Stock, XNAS:EXEL
1851 Harbor Bay Parkway, Alameda, California 94502
United States of America
Phone: +1.650.837.7000
Number of Employees: 1147
Description
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.